| Date |
Description |
Download |
| 15 Apr.2024 |
NextFerm Announces Signing an MOU with Kothari for Production and Marketing of Yeast Extract in India in India |
Hebrew PDF
|
| 01 Apr.2024 |
NextFerm's Commercial Production Line Successfully Passed FSSC 22000 Audit |
English PDF
Hebrew PDF
|
| 31 Mar.2024 |
NextFerm Reports Second Half and Full Year 2023 Financial Results |
English PDF
Hebrew PDF
|
| 25 Mar.2024 |
NextFerm Announces A successful completion of the production line commissioning for ProteVin™ in India |
English PDF
Hebrew PDF
|
| 14 Mar.2024 |
NextFerm Announces First Order for ProteVin™ in Spain for Sports Nutrition |
English PDF
Hebrew PDF
|
| 12 Mar.2024 |
NextFerm Announces a Successful Completion of First Production Line for ProteVin™ in India |
English PDF
Hebrew PDF
|
| 19 Feb.2024 |
NextFerm Publishes CEO Letter |
English PDF
Hebrew PDF
|
| 25 Jan.2024 |
NextFerm Announces a Successful Completion of Yeast Strain Scale-up for ProteVin™ Production |
Hebrew PDF
|
| 27 Nov.2023 |
NextFerm Updates Manufacturing Facility Establishment Progress |
Hebrew PDF
|
| 20 Aug.2023 |
NextFerm Reports First Half 2022 Financial Results |
Hebrew PDF
|
| 05 July.2023 |
NextFerm Announces a Commercial Manufacturing Agreement for ProteVin™ |
English PDF
Hebrew PDF
|
| 28 Mar.2023 |
NextFerm Announces Third Launch of ProteVin™ in US |
Hebrew PDF
|
| 23 Mar.2023 |
NextFerm Reports Fourth Quarter and Full Year 2022 Financial Results |
English PDF
Hebrew PDF
|
| 28 Feb.2023 |
NextFerm Announces Filing of a Shelf Offering Report for raising up to NIS 54M |
Hebrew PDF
|
| 22 Nov.2022 |
NextFerm Reports Third Quarter 2022 Financial Results |
Hebrew PDF
|
| 13 Nov.2022 |
NextFerm Announces Distribution Agreement in South Korea for ProteVin™ & A Commercial PO From Germany |
Hebrew PDF
|
| 24 Oct.2022 |
NextFerm Announces filing a patent for ProteVin™ |
English PDF
Hebrew PDF
|
| 08 Sep.2022 |
NextFerm Announces a Strategic Manufacturing Agreement for ProteVin™ |
English PDF
Hebrew PDF
|
| 18 Aug.2022 |
NextFerm Reports Second Quarter 2022 Financial Results |
English PDF
Hebrew PDF
|
| 08 Aug.2022 |
NextFerm Announces a $3 million Supply agreement for its vegan protein: ProteVin™ |
English PDF
Hebrew PDF
|
| 22 June.2022 |
NextFerm Announces US Launch of ProteVin™ |
English PDF
Hebrew PDF
|
| 19 June.2022 |
NextFerm Announces First Commercial Production of ProteVin™ |
English PDF
Hebrew PDF
|
| 23 May.2022 |
NextFerm Reports First Quarter 2022 Financial Results |
Hebrew PDF
|
| 14 Mar.2022 |
NextFerm Reports Fourth Quarter and Full Year 2021 Financial Results |
English PDF
Hebrew PDF
|
| 29 Dec.2021 |
NextFerm Technologies Announces Commercial production agreement for ProteVin™ with GFR Ingredients. |
English PDF
Hebrew PDF
|
| 18 Nov.2021 |
NextFerm Technologies Announces Closing of $8.7M Private Placement |
Hebrew PDF
|
| 08 Nov.2021 |
NextFerm Reports Third Quarter 2021 Financial Results |
Hebrew PDF
|
| 14 Oct.2021 |
NextFerm Technologies Announces Commercial Purchase Order of ProteVin™ from CleanMachine® |
Hebrew PDF
|
| 01 Sep.2021 |
NextFerm Technologies Announces a Regulatory marketing approval of Astaferm® in Oil for Soft-Gels, in the US |
English PDF
Hebrew PDF
|
| 19 Aug.2021 |
NextFerm Technologies Announces First Commercial Purchase Order of Astaferm® in the Canada |
Hebrew PDF
|
| 19 Aug.2021 |
NextFerm Reports Second Quarter 2021 Financial Results |
Hebrew PDF
|
| 25 July.2021 |
NextFerm Technologies Announces First Commercial Purchase Order of ProteVin™ in the US |
English PDF
Hebrew PDF
|
| 11 July.2021 |
NextFerm Technologies Announces a Regulatory marketing approval of Astaferm® in Canada |
English PDF
Hebrew PDF
|
| 06 June.2021 |
NextFerm Technologies Announces a Successful Industrial Pilot Of ProteVin™ |
English PDF
Hebrew PDF
|
| 27 May.2021 |
NextFerm Reports First Quarter 2021 Financial Results |
English PDF
Hebrew PDF
|
| 22 Mar.2021 |
NextFerm Reports Fourth Quarter and Full Year 2020 Financial Results |
Hebrew PDF
|
| 22 Feb.2021 |
NextFerm Technologies announces Launch of its antioxidant Astaferm® Gummies by Carlson Labs, a Leading US Dietary Supplement Company |
Hebrew PDF
|
| 02 Feb.2021 |
Management of NextFerm Technologies Opens Trading in Celebration of Its IPO on TASE |
Hebrew PDF
|
| 24 Jan.2021 |
NextFerm Technologies Announces Closing of Initial Public Offering |
Hebrew PDF
|
